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A solution pathway for preterm birth: accelerating a priority 
research agenda
Although important gains have been made in child 
survival over the past two decades, reduction in 
neonatal mortality (ie, deaths in the ﬁ rst month of 
life) has lagged substantially. Neonatal deaths now 
account for 44% of all under-5 deaths worldwide.1 
Preterm birth is the leading cause of neonatal death, 
the second leading cause of all under-5 mortality,2 
and a leading cause of severe childhood neurological 
disability. Despite this high global burden, little is 
known about how to prevent preterm birth and, in 
low-income and middle-income countries, how best 
to scale up strategies that are practical and aﬀ ordable. 
Preterm birth is a ﬁ nal common pathway for many 
complex pathological processes. A comprehensive 
research agenda is therefore needed to accelerate 
identiﬁ cation of mediators of preterm birth and 
innovative solutions. To forge a road map for this 
action agenda, the Bill & Melinda Gates Foundation 
(BMGF), the Global Alliance to Prevent Prematurity and 
Stillbirth (GAPPS), March of Dimes (MOD), the Eunice 
Kennedy Shriver National Institute of Child Health and 
Human Development, and WHO convened meetings 
of experts to develop a research agenda that spans 
the range of discovery, development, and delivery 
science needed to drive global change. This Comment 
summarises this solution pathway (ﬁ gure) and the next 
steps toward its implementation. 
Growing political will and new technological oppor-
tunities make this an opportune time to reinvigorate a 
new initiative for preterm birth research. Multiple global 
initiatives have gained crucial momentum to address 
neonatal mortality and preterm birth, including the 
Millennium Development Goals, Every Woman Every 
Child, and the Every Newborn global action plan.3–6 An 
essential element of these eﬀ orts is the development 
of new solutions to achieve health targets. Scientiﬁ c 
advancements in the past decade have created a new 
opportunity for transformative research into the complex 
biology of pregnancy, including computational biology, 
genomics, informatics, microbiology, immunology, social 
network analysis, cell biology, imaging, nanotechnologies, 
and implementation science.
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 Figure: Summary of the preterm research solution pathway
The schematic summarises key elements of the solution pathway for preterm birth research, across the range of discovery, development, and delivery science. 
The agenda is global in its approach; strategies more relevant to high-income countries are in pink, and low-income and middle-income countries (LMIC) in grey. 
CPAP = continuous positive airway pressure. EmONC = emergency obstetric and newborn care. RMNCH = reproductive, maternal, newborn, and child health.
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The ﬁ rst element of a solution pathway for preterm 
birth is an understanding of the biology of pregnancy 
and novel targets for preterm prevention. Most cases 
of preterm birth are spontaneous or follow premature 
rupture of membranes, usually with no identiﬁ able 
cause. Multiple factors are associated with preterm birth 
including family history, reproductive tract and remote 
site infections, inﬂ ammation, nutrition, race, poverty, 
and emotional and physical stress.7,8 Investigation of 
these interrelated factors and their biological networks 
leading to preterm birth will be needed to advance 
prevention.
To understand how uterine and cervical tissues 
remain quiescent, sustain pregnancy, and later initiate 
contractility and remodelling, insights into molecular 
regulation of pregnancy are needed.9 Priorities include 
investigations of fetal–placental signalling of onset 
of labour and genomic, transcriptomic, proteomic, 
immunological, and metabolomic analyses. 
The microbiome presents another important target 
for investigation. Female genital tract infections, altered 
microbiota, and associated inﬂ ammatory processes 
are strongly associated with preterm birth, particularly 
very preterm birth.10 Research is needed into microbial 
perturbations, immune responses, and interactions 
of microbiota with host and environmental factors. 
Investigations in low-income and middle-income 
countries are needed where microbial, host, and 
environmental milieux diﬀ er substantially.
The expansion of the application of genomics, 
transcriptomics, and related technologies oﬀ ers 
new opportunities to identify genes, pathways, and 
associated factors that regulate parturition and their 
functions,11 including epigenetic and gene–environment 
investigations. Large-scale studies will be needed to 
address these complex investigations. 
Rates of preterm birth and preterm-related 
mortality vary signiﬁ cantly by race, ethnic origin, 
and socioeconomic strata.7,8 Biological mediators 
of disparities, however, remain largely unknown. 
Investigations into genetic, hormonal, microbial, 
inﬂ ammatory, nutritional, and environmental factors, 
and their interactions with social, emotional, physical, 
and environmental stressors will elucidate causality and 
identify strategies for prevention and care. 
Prevention of preterm birth requires the early 
identiﬁ cation of women at risk. Accelerated application 
of novel methods, including systems biology and network 
analyses, will help to identify signals that drive parturition. 
Genetic, inﬂ ammatory, hormonal, and growth factors 
based on positive and negative feedback mechanisms 
can identify new biomarkers. Novel biotechnologies 
allow non-invasive monitoring of the maternal–fetal 
environment, by use of imaging, nanotechnology, and 
assessment of metabolic activity and signal cascades. 
Adaptations of existing technologies for low-income 
and middle-income countries are needed to improve 
assessment of gestational age, cervical length, and 
pregnancy monitoring.
The second element of a solution pathway for preterm 
birth is to improve the survival of preterm infants in 
low-income and middle-income countries. Practical 
solutions need to be developed and moved to scale to 
improve care. An expanded implementation science 
agenda will accelerate application of eﬀ ective strategies 
at the community and facility level, including antenatal 
corticosteroids, newborn resuscitation, kangaroo mother 
care, nutrition, intrapartum monitoring, newborn skin 
emollients, chlorhexidine cord care, preconception 
care, and strengthened commodities and essential drug 
programmes.12 Adaptations of interventions for newborn 
care are needed, including simpliﬁ ed continuous positive 
airway pressure, ventilators, high-ﬂ ow nasal cannulae, 
antibiotic regimens, and new surfactant formulations.
Intervention trials can assess eﬃ  cacy and advance 
understanding of the biology of pregnancy in high-
income and low-income settings. Examples include 
screening and treatment of infectious and non-
infectious proinﬂ ammatory processes and interventions 
that modulate immunological, microbial, and hormonal 
mediators.
The third element of the solution pathways is to 
improve the epidemiological data needed to track 
prevalence, risk factors, and programme eﬀ ect. Accurate 
and standardised reporting of gestational age, preterm-
related death, classiﬁ cation of preterm phenotypes, and 
health service coverage are needed in essential registries 
and surveys in all countries.
The ﬁ nal element of the solution pathway is to 
accelerate health gains by fostering innovation and 
collaboration. New approaches to research are needed 
that promote innovation and rapid translation of science 
to action. Transdisciplinary and multidimensional 
approaches are needed that examine interactions among 
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complex biological mediators and health disparities. New 
models of funding can promote collaboration between 
investigators and across disciplines. Standardised 
databases and biorepositories will accelerate discovery, 
development, and delivery science.
The opportunity exists now to generate new 
knowledge and solutions that can move rapidly to health 
gains. To this end, BMGF, GAPPS, MOD, the US National 
Institutes of Health, and WHO have initiated eﬀ orts 
to forge a new coalition to advance the visibility and 
research needed to drive global change. The coalition 
is intended to be inclusive of other key stakeholders, 
inviting participation of governmental and multilateral 
organisations, foundations, and corporations that 
support research into maternal–newborn health and are 
committed to an accelerated agenda to reduce death and 
disability due to preterm birth. Finding solutions to the 
complex problem of preterm birth will not come easily, 
but will need an expanded strategic initiative. Time and 
again results have shown that investment in science 
yields health solutions. Now is a crucial time to eﬀ ect 
such advancements for preterm birth.
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